NL-OMON52958已完成不适用
CONVINCE An international, multi-centre, prospective, randomised, controlled study comparing high-dose Haemodiafiltration (HDF) versus conventional high-flux Haemodialysis (HD). - CONVINCE
niversitair Medisch Centrum Utrecht0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Signed and dated written Informed Consent Form.
- •2. Male or female aged >= 18 years.
- •3. Diagnosed with ESKD.
- •4. On HD treatment for >= 3 months.
- •5. Likely to achieve high-dose HDF (>= 23 L adjusted to BSA/session, in
- •post-dilution mode)
- •6. Willing to have a dialysis session with duration of >= 4 hours, three times a
- •7. Understands study procedures and is able to comply.
排除标准
- •1. Severe subject non-compliance defined as severe non-adherence to the
- •dialysis procedure and accompanying prescriptions, especially frequency and
- •duration of dialysis treatment.
- •2. Life expectancy < 3 months.
- •3. HDF treatment < 90 days before screening.
- •4. Anticipated living donor kidney transplantation < 6 months after screening.
- •5. Evidence of any other diseases or medical conditions that may interfere with
- •the planned treatment, affect subject compliance or place the subject at high
- •risk for treatment-related complications.
- •6. Participation in any other study will be discussed with and decided by the
- •Executive Board depending on the extent of interference on this study.
- •Registries are expected to be approved.
- •7. Unavailable >= 3 months during the study conduct for study visits.
研究者
相似试验
尚未招募
不适用
A MULTICENTER, MULTINATIONAL, PROSPECTIVE, INTERVENTIONAL, SINGLE-ARM, PHASE IV STUDY EVALUATING THE CLINICAL EFFICACY AND SAFETY OF 26 WEEKS OF TREATMENT WITH INSULIN GLARGINE 300 U/ML (GLA-300) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS UNCONTROLLED ON BASAL INSULI-E10 Insulin-dependent diabetes mellitusInsulin-dependent diabetes mellitusE10PER-009-19Sanofi Aventis Recherche & Development,26
尚未招募
4 期
A study to find out if Toujeo is safe and efficient in patients with Ty 2 DM, who previously were taking another basal insulin but wasnt efficient. A basal insulin is secreted continuously during the day into the bloodstream from SC depot, when a natural secretion from pancreas is reduced.CTRI/2019/08/020701SanofiAventis Groupe
Unknown
4 期
A multicenter, multinational, prospective, interventional, single-arm, Phase IV study evaluating the clinical efficacy and safety of 26 weeks of treatment with insulin glargine 300 U/mL (Gla-300) in patients with Type 2 diabetes mellitus uncontrolled on basal insuliPatients with Type 2 diabetes mellitus uncontrolled on basal insulinK63.9DiabetesLBCTR2019040212Sanofi11
已完成
不适用
Observational study to evaluate the safety and performance of an anti-bacterial wound dressingCTRI/2021/07/034509Essity India Private Limited112
已完成
不适用
An Observational, Prospective Evaluation of the St Jude Medical Epic ValveStructural Valve Deterioration (SVD)Central regurgitationcalcification of the valveThrombus or Pannus formationCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemCardiovascular - Coronary heart diseaseACTRN12610000023055St. Jude Medical300